\
&
Contact us
\
&
Contact us
Published on | 1 year ago
Programmes CybersecurityThe European Commission has opened today a new call on Deploying The Network of National Coordination Centres with Member States (DIGITAL-ECCC-2024-DEPLOY-NCC-06-MS-COORDINATION).
With the creation of the European Cybersecurity Industrial, Technology and Research Competence Centre, the National Coordination Centres (NCCs) – working together through a network – will contribute to foster the Cybersecurity Competence Community in each Member State, contributing to acquire the necessary capacity. National Coordination Centres can also support priority areas such as the implementation of relevant EU legislation. The objective of this call is to support the operation of the NCCs and to enable them to support the cybersecurity community, including SMEs, for the uptake and dissemination of state-of-the-art cybersecurity solutions and strengthen cybersecurity capacities.
This call has two cut-off dates to submit proposals: 29 May 2024 and 28 November 2024.
More information on the call can be found in the call document.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
